
[TimAlerts] VBLT. Clinical Data Presented at ASCO Demonstrate Significant Overall Survival Benefit in rGBM Patients Receiving VB-111 Compared with Historical Avastin® Meta-analysis Data http://finance.yahoo.com/news/clinical-data-presented-asco-demonstrate-200200082.html